Elisabeth Sandoval Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Elisabeth Sandoval.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Elisabeth Sandoval. Elisabeth Sandoval is in Intersect ENT, Inc. ($XENT) and CCO & EVP, Corporate Strategy in ALDER BIOPHARMACEUTICALS INC ($ALDR) and Chief Commercial Officer in ALDER BIOPHARMACEUTICALS INC ($ALDR) and Chief Commercial Officer in KYTHERA BIOPHARMACEUTICALS INC ($KYTH) and Chief Commerical Officer in KYTHERA BIOPHARMACEUTICALS INC ($KYTH) and Director in Menlo Therapeutics Inc. ($MNLO) and Director in Satsuma Pharmaceuticals, Inc. ($STSA).
Latest Insider Trading Transactions of Elisabeth Sandoval
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALDR, XENT, KYTH, STSA, MNLO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 07 2021 | XENT | Intersect ENT, Inc ... | Sandoval Elisabeth | Option Exercise | A | 20.98 | 15,896 | 333,498 | 15,896 | ||
| Aug 05 2020 | MNLO | Menlo Therapeutics ... | Sandoval Elisabeth | Director | Option Exercise | A | 1.72 | 22,500 | 38,700 | 22,500 | |
| Jun 16 2020 | STSA | Satsuma Pharmaceut ... | Sandoval Elisabeth | Director | Option Exercise | A | 26.99 | 10,000 | 269,900 | 10,000 | |
| Mar 23 2020 | MNLO | Menlo Therapeutics ... | Sandoval Elisabeth | Director | Option Exercise | A | 2.67 | 45,000 | 120,150 | 45,000 | |
| Jun 27 2019 | MNLO | Menlo Therapeutics ... | Sandoval Elisabeth | Director | Option Exercise | A | 6.02 | 11,645 | 70,103 | 45,000 | |
| Mar 21 2019 | MNLO | Menlo Therapeutics ... | Sandoval Elisabeth | Director | Option Exercise | A | 8.24 | 33,355 | 274,845 | 33,355 | |
| Feb 21 2018 | ALDR | ALDER BIOPHARMACEU ... | Sandoval Elisabeth | CCO & EVP, Corporat ... | Option Exercise | A | 13.55 | 60,000 | 813,000 | 60,000 | |
| Dec 21 2017 | ALDR | ALDER BIOPHARMACEU ... | Sandoval Elisabeth | Chief Commercial Of ... | Option Exercise | A | 10.95 | 150,000 | 1,642,500 | 150,000 | |
| Jan 31 2017 | ALDR | ALDER BIOPHARMACEU ... | Sandoval Elisabeth | Chief Commercial Of ... | Option Exercise | A | 20.40 | 75,000 | 1,530,000 | 75,000 | |
| Oct 07 2016 | ALDR | ALDER BIOPHARMACEU ... | Sandoval Elisabeth | Chief Commercial Of ... | Option Exercise | A | 31.47 | 225,000 | 7,080,750 | 225,000 | |
| Oct 02 2015 | KYTH | KYTHERA BIOPHARMAC ... | Sandoval Elisabeth | Chief Commerical Of ... | Option Exercise | D | 38.53 | 45,344 | 1,747,104 | 0 | |
| Oct 02 2015 | KYTH | KYTHERA BIOPHARMAC ... | Sandoval Elisabeth | Chief Commerical Of ... | Option Exercise | D | 44.02 | 15,608 | 687,064 | 0 | |
| Oct 02 2015 | KYTH | KYTHERA BIOPHARMAC ... | Sandoval Elisabeth | Chief Commerical Of ... | Option Exercise | D | 27.50 | 6,700 | 184,250 | 0 | |
| Oct 02 2015 | KYTH | KYTHERA BIOPHARMAC ... | Sandoval Elisabeth | Chief Commerical Of ... | Option Exercise | D | 8.22 | 45,588 | 374,907 | 0 | |
| Oct 02 2015 | KYTH | KYTHERA BIOPHARMAC ... | Sandoval Elisabeth | Chief Commerical Of ... | Sell | D | 0.00 | 575 | 0 | 0 | 575 to 0 (-100.00 %) |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Sandoval Elisabeth | Chief Commercial Of ... | Option Exercise | M | 44.02 | 11,150 | 490,823 | 15,608 | |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Sandoval Elisabeth | Chief Commercial Of ... | Option Exercise | M | 27.50 | 13,400 | 368,500 | 6,700 | |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Sandoval Elisabeth | Chief Commercial Of ... | Option Exercise | M | 27.50 | 13,400 | 368,500 | 0 | |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Sandoval Elisabeth | Chief Commercial Of ... | Option Exercise | M | 8.22 | 22,690 | 186,512 | 0 | |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Sandoval Elisabeth | Chief Commercial Of ... | Option Exercise | M | 8.22 | 11,892 | 97,752 | 4,857 | |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Sandoval Elisabeth | Chief Commercial Of ... | Option Exercise | M | 8.22 | 10,590 | 87,050 | 16,749 | |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Sandoval Elisabeth | Chief Commercial Of ... | Sell | S | 74.90 | 11,150 | 835,135 | 0 | 11.2 K to 0 (-100.00 %) |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Sandoval Elisabeth | Chief Commercial Of ... | Buy | M | 44.02 | 11,150 | 490,823 | 11,150 | 0 to 11.2 K |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Sandoval Elisabeth | Chief Commercial Of ... | Sell | S | 74.90 | 26,800 | 2,007,320 | 0 | 26.8 K to 0 (-100.00 %) |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Sandoval Elisabeth | Chief Commercial Of ... | Buy | M | 27.50 | 26,800 | 737,000 | 26,800 | 0 to 26.8 K |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Sandoval Elisabeth | Chief Commercial Of ... | Sell | S | 74.90 | 22,690 | 1,699,481 | 0 | 22.7 K to 0 (-100.00 %) |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Sandoval Elisabeth | Chief Commercial Of ... | Buy | M | 8.22 | 22,690 | 186,512 | 22,690 | 0 to 22.7 K |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Sandoval Elisabeth | Chief Commercial Of ... | Sell | S | 74.90 | 11,892 | 890,711 | 0 | 11.9 K to 0 (-100.00 %) |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Sandoval Elisabeth | Chief Commercial Of ... | Buy | M | 8.22 | 11,892 | 97,752 | 11,892 | 0 to 11.9 K |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Sandoval Elisabeth | Chief Commercial Of ... | Sell | S | 74.90 | 10,590 | 793,191 | 0 | 10.6 K to 0 (-100.00 %) |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Sandoval Elisabeth | Chief Commercial Of ... | Buy | M | 8.22 | 10,590 | 87,050 | 10,590 | 0 to 10.6 K |
| Aug 06 2015 | KYTH | KYTHERA BIOPHARMAC ... | Sandoval Elisabeth | Chief Commercial Of ... | Sell | S | 74.75 | 2,728 | 203,918 | 0 | 2.7 K to 0 (-100.00 %) |
| Apr 30 2015 | KYTH | KYTHERA BIOPHARMAC ... | Sandoval Elisabeth | Chief Commercial Of ... | Sell | S | 45.55 | 1,654 | 75,340 | 2,728 | 4.4 K to 2.7 K (-37.75 %) |
| Apr 30 2015 | KYTH | KYTHERA BIOPHARMAC ... | Sandoval Elisabeth | Chief Commercial Of ... | Grant | A | 0.00 | 4,382 | 0 | 4,382 | 0 to 4.4 K |
Page: 1